123 related articles for article (PubMed ID: 210295)
1. Suppression and immunotherapy of the guinea pig line-10 hepatocarcinoma mediated by nonviable Staphylococcus aureus.
Minden P; McClatchy JK; Brunda MJ
J Natl Cancer Inst; 1978 Aug; 61(2):535-8. PubMed ID: 210295
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma.
Bast RC; Zbar B; Miller TE; Mackaness GB; Rapp HJ
J Natl Cancer Inst; 1975 Mar; 54(3):757-61. PubMed ID: 164568
[TBL] [Abstract][Full Text] [Related]
3. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
Minden P; Mathews HL
Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
Hanna MG; Peters LC
Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
[TBL] [Abstract][Full Text] [Related]
5. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Fidler IJ; Kataoka T; Hanna MG
Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
[TBL] [Abstract][Full Text] [Related]
6. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG.
Harmel RP; Zbar B; Rapp HJ
J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537
[TBL] [Abstract][Full Text] [Related]
7. Suppression of growth of guinea pig line-10 hepatocarcinoma. I. Effect of simultaneous administration of tumor cells and antibodies from normal rabbits.
Brunda MJ; Minden P; Heusser CH; Ferguson HR
J Immunol; 1978 Mar; 120(3):831-6. PubMed ID: 75927
[TBL] [Abstract][Full Text] [Related]
8. Complete regression of a guinea pig hepatocarcinoma by immunotherapy with "tumor-immune" RNA or antibody to fibrin fragment E.
Schlager SI; Dray S
Isr J Med Sci; 1976; 12(4-5):344-59. PubMed ID: 181352
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.
Key ME; Brandhorst JS; Hanna MG
J Immunol; 1983 Jun; 130(6):2987-92. PubMed ID: 6304194
[TBL] [Abstract][Full Text] [Related]
10. Intratumor chemoimmunotherapy with mitomycin C and components from mycobacteria in regression of line 10 tumors in guinea pigs.
McLaughlin CA; Cantrell JL; Ribi E; Goldberg EP
Cancer Res; 1978 May; 38(5):1311-6. PubMed ID: 205361
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of the guinea pig line 10 hepatocarcinoma with a variety of nonviable bacteria.
Brunda MJ; Mathews HL; Ferguson HR; McClatchy JK; Minden P
Cancer Res; 1980 Sep; 40(9):3211-3. PubMed ID: 6775802
[TBL] [Abstract][Full Text] [Related]
12. Complete and apparently specif local tumor regression using syngeneic or xenogeneic "tumor-immune" RNA extracts.
Schlager SI; Paque RE; Dray S
Cancer Res; 1975 Aug; 35(8):1907-14. PubMed ID: 167938
[TBL] [Abstract][Full Text] [Related]
13. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ
Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
[TBL] [Abstract][Full Text] [Related]
14. Administration of antigen by intralymphatic route in the rat. II. Results in tumor active immunotherapy (delta). Preliminary report.
Sulis E; Busilacchi M; Turno R; Monni A; Chessa A; Zizi P; Pani P; Manconi PE
Boll Ist Sieroter Milan; 1976 Jul; 55(3):252-4. PubMed ID: 189786
[TBL] [Abstract][Full Text] [Related]
15. Complete local tumor regression with antibody to fibrin Fragment E.
Schlager SI; Dray S
J Immunol; 1975 Oct; 115(4):976-81. PubMed ID: 170340
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of tumor rejection by trypan blue.
Kreider JW; Bartlett GL; DeFreitas E
Cancer Res; 1978 Apr; 38(4):1036-40. PubMed ID: 205342
[TBL] [Abstract][Full Text] [Related]
17. Enhanced immunogenicity of line 10 guinea pig hepatocarcinoma cells after culture.
Correll LL; Nielsen LD; Kelleher PJ; Harbell JW; Minden P
J Natl Cancer Inst; 1983 Dec; 71(6):1343-6. PubMed ID: 6581367
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte migration inhibition of tumor antigen and purified protein derivative reactivity in guinea pigs sensitized to line 10 hepatocarcinoma and BCG.
McCoy JL; Brandhorst J; Hanna MG
J Natl Cancer Inst; 1978 Mar; 60(3):693-9. PubMed ID: 75270
[TBL] [Abstract][Full Text] [Related]
19. Growth of transplanted rat tumors following administration of cell-free tumor antigens.
Tracey RS; Wepsic HT; Alaimo J; Morris HP
Cancer Res; 1978 May; 38(5):1208-12. PubMed ID: 205357
[TBL] [Abstract][Full Text] [Related]
20. Suppression of the line-10 guinea pig hepatocarcinoma by antigens related to both Mycobacterium bovis (BCG) and the tumor.
Minden P; Mathews HL; Kelleher PJ
J Immunol; 1980 Dec; 125(6):2685-9. PubMed ID: 7000904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
